Article citationsMore>>

T. A. Yap, D. Olmos, L. R. Molife and J. S. de Bono, “Targeting the Insulin-Like Growth Factor Signaling Pathway: Figitumumab and Other Novel Anticancer Strategies,” Expert Opinion Investigatinal Drugs, Vol. 20, No. 9, 2011, pp. 1293-1304. doi:10.1517/13543784.2011.602630

has been cited by the following article:

• TITLE: Lactic Acidosis and Atrial Tachycardia: Unusual Presentations of Disseminated Burkitt-Like Lymphoma

  AUTHORS: Hazem El-Osta, Abdulrahman Abdulbaki, Prakash Peddi, Amol Takalkar, James Cotelingam, Diana Veillon, Andres Vargas, Nuri Akkus, Gerhard C. Hildebrandt

  KEYWORDS: Atrial Tachycardia; Burkitt-Like Lymphoma; B-Cell Lymphoma; Intra-Cardiac Tumor; Hypoglycemia; Lactic Acidosis

  JOURNAL NAME: Journal of Cancer Therapy, Vol.3 No.5, October 18, 2012

  ABSTRACT: Lactic acidosis is a rare complication of malignancies and is seen more frequently in high grade lymphoma and leukemia. Although, its pathogenesis is not well understood, it remains a surrogate of poor prognosis. Herein, we present a case of Burkitt-like lymphoma presenting with metabolic abnormalities including lactic acidosis and hypoglycemia along with atrial tachycardia. We will discuss the different mechanisms involved in these metabolic disturbances and we will provide insight on novel therapeutic strategies based on our understanding of the underlying pathophysiology.